RxDoctor Payments Data

Stephen Nester, MD

Family Medicine · Saint Louis, MONPI 1871574582

Payments from drug & device makers

$11,945in general payments, 2019–2025

Across 807 payments — averaging $14.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$1K
  • GSK$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$802
  • Boehringer Ingelheim$600
  • plus $5K from 47 others

What the payments were for

  • Food & beverage$11,918100%
  • Education$120%
  • Entertainment$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,945 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$46,152
Medicare patients
158
Services billed
1,467

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban180$152,016
OzempicSemaglutide138$138,693
MounjaroTirzepatide39$58,375
RybelsusSemaglutide31$51,566
XareltoRivaroxaban48$43,864
JardianceEmpagliflozin29$36,914
EntrestoSacubitril/Valsartan28$26,548
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog33$21,787
TrulicityDulaglutide20$20,633
Breo ElliptaFluticasone/Vilanterol36$18,541
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog31$18,409
MyrbetriqMirabegron19$17,116
Semglee (Yfgn) PenInsulin Glargine-Yfgn36$17,065
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$16,635
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$14,808

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,098$190,259169 claims
PfizerEliquis, Abrysvo$1,254$157,537198 claims
Lilly USA, LLCMounjaro, Trulicity$802$79,00859 claims
GSKBreo Ellipta, Trelegy Ellipta, Arexvy, Anoro Ellipta, Arnuity Ellipta$1,119$56,268125 claims
Johnson & JohnsonXarelto$167$43,86448 claims
Boehringer IngelheimJardiance$600$36,91429 claims
NovartisEntresto$322$26,54828 claims
Astellas Pharma US IncMyrbetriq$396$17,11619 claims
AstraZenecaFarxiga$496$13,14911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →